基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 原料药 循环系统用药 抗高血压病药 盐酸贝那普利 盐酸贝那普利
  • 盐酸贝那普利

盐酸贝那普利

Benazepril Hydrochloride
86541-74-4
福建 更新日期:2012-08-16

福建汇天生物药业有限公司

非会员
联系人:陈女士
电话:0598-8300113拨打
邮箱:1026305756@qq.com

产品详情:

中文名称:
盐酸贝那普利
英文名称:
Benazepril Hydrochloride
CAS号:
86541-74-4
[Chemical name] (3S)-3-[[(1S)-1-Carboxy-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, 3-ethyl ester, monohydrochloride [Molecular Formula] C24H28N2O5•HCl [Molecular Weight] 460.96 [CAS Number] 86541-74-4 [Description] White or off white crystalline powder [Quality Standard] CP:YBH00812008 ; USP 32 [Packing] 20KG/Drum [Function and Indication] 1. It’s an ACE inhibitor used for treating moderate hypertension 2. Advantages: 1) Definite curative effect; minimal side effect, clinically treat hypertensive and congestive heart failure 2) WHO recommended as first line anti-hypertension medicine 3) Reduce ventricular afterload without increasing heart rate, improve the status of left ventricular hypertrophy and the glucose tolerance of diabetics 4) Long inhibitory activity time of ACE, quick absorption rate after oral administration and no cumulative effect after repeated doses 2. Mechanism of Action: Upon cleavage of its ester group by the liver after oral administration, benazepril is converted into its active form benazeprilat, which later competitively combines with angiotensin-converting enzyme (ACE) to reduce the activity of angiotensin-converting enzyme (ACE) and to inhibit angiotensin I from converting to angiotensin II by angiotensin-converting enzyme (ACE). In this way, Benazepril Hydrochloridec reduces blood vessel resistance to achieve the goal of lowering blood pressure
anti-hypertension; Lotensin

成立日期 (27年)
注册资本 20000万人民币
员工人数
年营业额
经营模式
主营行业

盐酸贝那普利相关厂家报价

内容声明
拨打电话 立即询价